Day

November 10, 2020
Drugmaker Pfizer Inc. announced in a press release that early data from its COVID-19 vaccine trial indicates that the vaccine candidate has demonstrated high efficacy. The Phase 3 vaccine candidate’s early results were found in an interim analysis by an independent data monitoring board to be more than 90% effective in preventing COVID-19 in participants...
Read More
Skip to content document.addEventListener('DOMContentLoaded', function() { var videos = document.querySelectorAll('video.wp-video-shortcode'); videos.forEach(function(video) { video.muted = true; }); });